Gregory H. Bailey - 31 Mar 2026 Form 4 Insider Report for Serina Therapeutics, Inc. (SER)

Reporting relationship: Director
Issuer ticker: SER
Reported as of: 31 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 21 Apr 2026, 15:45:42 UTC
Prior SEC filing: 17 Nov 2025
Next SEC filing: 30 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Gregory Bailey

Key filing fact

Gregory H. Bailey filed Form 4 for Serina Therapeutics, Inc. (SER) on 21 Apr 2026.

Key facts

This page summarizes Gregory H. Bailey's Form 4 filing for Serina Therapeutics, Inc. (SER).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 21 Apr 2026, 15:45.

Change

Previous filing in this sequence was filed on 17 Nov 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001329505 Primary reporting owner

Bailey Gregory

Relationship: Director
Address: 601 GENOME WAY, SUITE 2001, HUNTSVILLE
Signature: /s/ Gregory Bailey
Signature date: 21 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SER transaction

Common Stock

Award

Transaction value
Shares: +59,667
Change %: +89%
Price: $1.94^*
Shares after: 126,910
Date: 31 Mar 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These shares of common stock were issued for payment of accrued dividends on the reporting individuals Series A Convertible Preferred Stock issued on April 8, 2025.